Does monocyte count have prognostic significance in cancer?

Leukemia Research

Volumn 37, Issue 10, 2013, Pages 1193-1194

  Tadmor, Tamar ^a,b  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CYCLOPHOSPHAMIDE; DOXORUBICIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISONE; RITUXIMAB; VINCRISTINE;

ABSOLUTE MONOCYTE COUNT; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CARDIOVASCULAR DISEASE; CELL COUNT; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DISEASE ASSOCIATION; EDITORIAL; FOLLICULAR LYMPHOMA; HODGKIN DISEASE; HUMAN; INFLAMMATION; LARGE CELL LYMPHOMA; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SEPSIS; STEM CELL NICHE; T CELL LYMPHOMA;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MONOCYTES; PREDNISONE; VINCRISTINE;

EID: 84883560601     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.07.035     Document Type: Editorial

References (14)

1. Watanabe R., Tomita N., Kishimoto K., et al. Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. Leuk Res 2013, 37:1208-1212.
2. Wilcox R.A., Ristow K., Habermann T.M., et al. The absolute monocyte count predicts overall survival in patients newly diagnosed with follicular lymphoma. Leuk Lymphoma 2012, 53(4):575-580.
3. Bari A., Tadmor T., Sacchi S., et al. Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas. Leuk Res 2013, 37(6):619-623.
4. Wilcox R.A., Ristow K., Habermann T.M., et al. The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. Leukemia 2011, 25(9):1502-1509.
5. Porrata L.F., Ristow K., Colgan J., et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin lymphoma. Haematologica 2012, 97(2):262-269.
6. Aprile von Hohenstaufen K., Conconi A., de Campos C.P., et al. Prognostic impact of monocyte count at presentation in mantle cell lymphoma. Br J Haematol 2013 Jun 29.
7. Elliott M.A., Verstovsek S., Dingli D., et al. Monocytosis is an adverse prognostic factor for survival in younger patients withprimary myelofibrosis. Leuk Res 2007, 31(11):1503-1509.
8. Tsai Y.D., Wang C.P., Chen C.Y., et al. Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity head and neck cancer. Head Neck 2013 Jun 4, [Epub ahead of print].
9. Rochet N.M., Kottschade L.A., Grotz T.E., Porrata L.F., Markovic S.N. The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma. Am J Clin Oncol 2013 Jun 14, [Epub ahead of print].
10. Sáenz J.J., Izura J.J., Manrique A., Sala F., Gaminde I. Early prognosis in severe sepsis via analyzing the monocyte immunophenotype. Intensive Care Med 2001 Jun, 27(6):970-977.
11. Urra X., Villamor N., Amaro S., et al. Monocyte subtypes predict clinical course and prognosis in human stroke. J Cereb Blood Flow Metab 2009, 29(5):994-1002.
12. Tadmor T., Fell R., Polliack A., Attias D. Absolute monocytosis at diagnosis correlates with survival in diffuse large B-celllymphoma-possible link with monocytic myeloid-derived suppressor cells. Hematol Oncol 2013, 31(2):325-331.
13. Liu G.X., Zhang X., Li S., Koiiche R.D., Sindsceii J.H., Song H. Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma. Tumour Biol 2013 May 9, [Epub ahead of print].
14. Steidl C., Lee T., Shah S.P., et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010 Mar 11, 362(10):875-885.